Publication Name	World Journal of Gastroenterology
Manuscript ID	78409
Country	United States

Received	2022-06-24 19:29
Peer-Review Started	2022-06-24 19:32
First Decision by Editorial Office Director	2022-07-11 23:10
Return for Revision	2022-07-11 23:10
Revised	2022-07-26 01:12
Publication Fee Transferred
Second Decision by Editor	2022-08-22 03:07
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2022-08-25 19:55
Articles in Press	2022-08-25 19:55
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-09-06 13:04
Publish the Manuscript Online	2022-09-15 13:37

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Combination strategies for pharmacologic treatment of non-alcoholic steatohepatitis
Manuscript Source	Invited Manuscript
All Author List	Jaspreet Suri, Sebastian Borja and Joseph K Lim
Funding Agency and Grant Number
Corresponding Author	Joseph K Lim, MD, Professor, Section of Digestive Diseases, Yale University School of Medicine, Yale Liver Center, 333 Cedar Street, LMP 1080, New Haven, CT 06520, United States. joseph.lim@yale.edu
Key Words	Non-alcoholic steatohepatitis; Fatty liver; Combination treatment; Drug therapy; Pharmacologic treatment; Clinical trials
Core Tip	Multimodal combination approaches targeting two or more molecular pathways contributing to steatohepatitis and liver fibrosis are needed to augment efficacy of novel investigational drug regimens to achieve non-alcoholic steatohepatitis (NASH) resolution and NASH fibrosis improvement.
Publish Date	2022-09-15 13:37
Citation	Suri J, Borja S, Lim JK. Combination strategies for pharmacologic treatment of non-alcoholic steatohepatitis. World J Gastroenterol 2022; 28(35): 5129-5140
URL	https://www.wjgnet.com/1007-9327/full/v28/i35/5129.htm
DOI	https://dx.doi.org/10.3748/wjg.v28.i35.5129

Full Article (PDF)	WJG-28-5129.pdf
Full Article (Word)	WJG-28-5129.docx
Manuscript File	78409_Auto_Edited-LS.docx
Answering Reviewers	78409-Answering reviewers.pdf
Audio Core Tip	78409-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	78409-Conflict-of-interest statement.pdf
Copyright License Agreement	78409-Copyright license agreement.pdf
Peer-review Report	78409-Peer-review(s).pdf
Scientific Misconduct Check	78409-Bing-Fan JR-2.png
Scientific Editor Work List	78409-Scientific editor work list.pdf
CrossCheck Report	78409-CrossCheck report.pdf
CrossCheck Report	78409-CrossCheck.png